Clinical trial
Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease
NCT06071429 is registered in ClinicalTrials.gov with R3 Vascular Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease
- Lead sponsor
- R3 Vascular Inc.
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- April 11, 2025
- Completion date
- March 1, 2032
- Enrollment
- 300 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.